12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Ainos (NASDAQ:AIMD) stock rose 54.8% to $1.27 during Friday’s pre-market session. The market value of their outstanding…
Moleculin Reports Higher AML Complete Remission Rates And Durability With Additional Interim Subject Data
Annamycin in combination with Cytarabine (AnnAraC) achieves CRc rate of 62% (54% CR) in 1st and 2nd line AML subjects (N=13)Full MB-106 trial reaches 20 subjects with CRc of 45% in 1st – 7th line, with median
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday’s pre-market session. The company’s market cap…
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Kineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Redhill Biopharma (NASDAQ:RDHL) shares rose 11.1% to $0.99 during Tuesday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Moleculin Biotech (NASDAQ:MBRX) shares moved upwards by 8.7% to $0.72 during Tuesday’s after-market session. The market value…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Exicure (NASDAQ:XCUR) shares increased by 50.0% to $0.93 during Tuesday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Lexaria Bioscience (NASDAQ:LEXX) stock increased by 19.0% to $1.5 during Tuesday’s after-market session. The market value of…
Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
Moleculin Biotech Inc (NASDAQ: MBRX) provided a preliminary update on recent clinical activity from annamycin
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell
• Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter.
• Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.